We are live on ! Find out more
DA

DCF Advisers Portfolio holdings

AUM $375M
1-Year Est. Return 72.65%
This Fund
S&P 500
This Quarter Est. Return
+5.2%
1 Year Est. Return
+72.65%
3 Year Est. Return
+156.29%
5 Year Est. Return
+218.72%
10 Year Est. Return
–
AUM
$250M
AUM Growth
+$56M
Cap. Flow
+$44.7M
Cap. Flow %
17.87%
Top 10 Hldgs %
51.39%
Holding
108
New
15
Increased
21
Reduced
34
Closed
11

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$3.19M
2
MU icon
Micron Technology
MU
+$1.73M
3
C icon
Citigroup
C
+$1.45M
4
URNM icon
Sprott Uranium Miners ETF
URNM
+$1.1M
5
AMGN icon
Amgen
AMGN
+$818K

Top Sells

Rank Stock Value
1
REGN icon
Regeneron Pharmaceuticals
REGN
+$2.95M
2
AAPL icon
Apple
AAPL
+$2.23M
3
RVNC
Revance Therapeutics, Inc.
RVNC
+$1.15M
4
GLD icon
SPDR Gold Trust
GLD
+$916K
5
BHVN icon
Biohaven
BHVN
+$805K

Sector Composition

Rank Sector Weight
1 Healthcare 26.92%
2 Technology 16.18%
3 Communication Services 7.16%
4 Consumer Discretionary 6.33%
5 Financials 3.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IWM icon
26
iShares Russell 2000 ETF
IWM
$79.8B
$2.37M 0.95%
10,750
-750
-7% -$160K
C icon
27
Citigroup
C
$222B
$2.35M 0.94%
37,500
+23,500
+168% +$1.45M
JQC icon
28
Nuveen Credit Strategies Income Fund
JQC
$704M
$2.24M 0.89%
386,389
-35,611
-8% -$203K
TEVA icon
29
Teva Pharmaceuticals
TEVA
$40.8B
$2.04M 0.81%
113,000
-17,750
-14% -$311K
DE icon
30
Deere & Co
DE
$160B
$1.88M 0.75%
4,500
+1,000
+29% +$377K
AAPL icon
31
Apple
AAPL
$4.54T
$1.86M 0.75%
8,000
-10,000
-56% -$2.23M
URNM icon
32
Sprott Uranium Miners ETF
URNM
$1.76B
$1.86M 0.74%
40,500
+25,000
+161% +$1.1M
PRTA icon
33
Prothena Corp
PRTA
$425M
$1.8M 0.72%
107,500
– –
CSCO icon
34
Cisco
CSCO
$457B
$1.6M 0.64%
30,000
-2,500
-8% -$122K
IONS icon
35
Ionis Pharmaceuticals
IONS
$8.6B
$1.58M 0.63%
39,500
+16,500
+72% +$768K
GLD icon
36
PUT
SPDR Gold Trust
GLD
$131B
$1.58M 0.63%
+6,500
New +$1.49M
BHVN icon
37
Biohaven
BHVN
$2.03B
$1.55M 0.62%
31,000
-20,700
-40% -$805K
LFCR icon
38
Lifecore Biomedical
LFCR
$166M
$1.42M 0.57%
288,478
-2,206
-0.8% -$11.5K
B
39
Barrick Mining
B
$61.5B
$1.39M 0.56%
70,000
-37,500
-35% -$714K
GM icon
40
General Motors
GM
$80.4B
$1.35M 0.54%
30,000
-5,000
-14% -$232K
ZM icon
41
Zoom
ZM
$28.2B
$1.22M 0.49%
17,500
-12,500
-42% -$781K
MU icon
42
PUT
Micron Technology
MU
$930B
$1.19M 0.48%
+11,500
New +$1.2M
QCOM icon
43
Qualcomm
QCOM
$155B
$1.19M 0.48%
7,000
– –
SPOT icon
44
Spotify
SPOT
$103B
$1.17M 0.47%
3,165
-485
-13% -$161K
AAPL icon
45
PUT
Apple
AAPL
$4.54T
$1.17M 0.47%
5,000
+3,000
+150% +$670K
META icon
46
Meta Platforms (Facebook)
META
$1.42T
$1.14M 0.46%
2,000
– –
LNSR icon
47
LENSAR
LNSR
$61.5M
$1.1M 0.44%
240,600
-884
-0.4% -$4.09K
BOXX icon
48
Alpha Architect 1-3 Month Box ETF
BOXX
$13.1B
$1.08M 0.43%
9,875
– –
F icon
49
Ford
F
$58.5B
$1.06M 0.42%
100,000
– –
INTC icon
50
Intel
INTC
$455B
$1.06M 0.42%
45,000
+7,500
+20% +$187K
1
2
3 4 5

Similar funds

JIC
JRM Investment Counsel Omaha, Nebraska $375M AUM 13.43% 1-Year Est. Return
CIM
CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return
AIM
Access Investment Management Atlanta, Georgia $376M AUM 17.2% 1-Year Est. Return
MWM
McMill Wealth Management Norfolk, Nebraska $376M AUM 14.46% 1-Year Est. Return
RCP
RIT Capital Partners London, United Kingdom $374M AUM 25.18% 1-Year Est. Return
HPM
Helix Partners Management New York $374M AUM 136.73% 1-Year Est. Return
CAG
Compass Advisory Group Melville, New York $374M AUM 14.59% 1-Year Est. Return
LWMNY
Landmark Wealth Management (New York) Melville, New York $373M AUM 12.01% 1-Year Est. Return

DCF Advisers's Q3 2024 Portfolio in Review

As of Q3 2024, DCF Advisers held 108 positions worth $250M, up 29% from $194M the previous quarter. Its ten largest holdings account for 51% of the portfolio.

DCF Advisers deployed $44.7M of net new capital in Q3 2024, opening 15 new positions and adding to 21 existing holdings. Its largest new stake was NewAmsterdam Pharma: 34,000 shares worth $564K.

By sector, the portfolio is most concentrated in Healthcare at 27% of assets, down from 34% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Regeneron Pharmaceuticals, an estimated $2.95M trimmed.

  • DCF Advisers's largest Q3 2024 buy was NewAmsterdam Pharma: 34,000 shares worth $564K.
  • DCF Advisers added most to Amazon in Q3 2024, an estimated $3.19M increase.
  • DCF Advisers's biggest Q3 2024 reduction was Regeneron Pharmaceuticals, cutting an estimated $2.95M.
  • DCF Advisers fully exited Snowflake in Q3 2024, selling an estimated $439K.
  • DCF Advisers's ten largest holdings make up 51% of its $250M portfolio in Q3 2024.
  • DCF Advisers opened 15 new positions and closed 11 in Q3 2024.
  • DCF Advisers's portfolio value rose 29% quarter-over-quarter to $250M.

Based on DCF Advisers's 13F filing for Q3 2024, filed 13 Nov 2024.